Avricore Health Stock Cash Flow From Operations
| AVCR Stock | CAD 0.08 0.01 14.29% |
Avricore Health fundamentals help investors to digest information that contributes to Avricore Health's financial success or failures. It also enables traders to predict the movement of Avricore Stock. The fundamental analysis module provides a way to measure Avricore Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avricore Health stock.
Avricore | Cash Flow From Operations |
Avricore Health Company Cash Flow From Operations Analysis
Avricore Health's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Avricore Health Cash Flow From Operations | 660.4 K |
Most of Avricore Health's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avricore Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Avricore Cash Flow From Operations Driver Correlations
Understanding the fundamental principles of building solid financial models for Avricore Health is extremely important. It helps to project a fair market value of Avricore Stock properly, considering its historical fundamentals such as Cash Flow From Operations. Since Avricore Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Avricore Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Avricore Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
Avricore Discontinued Operations
Discontinued Operations |
|
In accordance with the recently published financial statements, Avricore Health has 660.4 K in Cash Flow From Operations. This is 99.87% lower than that of the Biotechnology sector and 99.82% lower than that of the Health Care industry. The cash flow from operations for all Canada stocks is 99.93% higher than that of the company.
Avricore Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avricore Health's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avricore Health could also be used in its relative valuation, which is a method of valuing Avricore Health by comparing valuation metrics of similar companies.Avricore Health is currently under evaluation in cash flow from operations category among its peers.
Avricore Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Avricore Health from analyzing Avricore Health's financial statements. These drivers represent accounts that assess Avricore Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Avricore Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.4M | 5.7M | 14.8M | 30.8M | 16.9M | 17.8M | |
| Enterprise Value | 1.4M | 6.4M | 12.8M | 30.2M | 16.7M | 17.5M |
Avricore Fundamentals
| Return On Equity | -0.0014 | ||||
| Return On Asset | 0.0151 | ||||
| Profit Margin | (0.0007) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 6.82 M | ||||
| Shares Outstanding | 100.94 M | ||||
| Shares Owned By Insiders | 10.19 % | ||||
| Number Of Shares Shorted | 5.75 K | ||||
| Price To Book | 3.24 X | ||||
| Price To Sales | 1.80 X | ||||
| Revenue | 3.49 M | ||||
| Gross Profit | 30.52 K | ||||
| EBITDA | 517.7 K | ||||
| Net Income | (701.22 K) | ||||
| Cash And Equivalents | 122.09 K | ||||
| Total Debt | 40 K | ||||
| Current Ratio | 1.80 X | ||||
| Book Value Per Share | 0.02 X | ||||
| Cash Flow From Operations | 660.4 K | ||||
| Short Ratio | 0.02 X | ||||
| Beta | -1.89 | ||||
| Market Capitalization | 8.08 M | ||||
| Total Asset | 2.54 M | ||||
| Retained Earnings | (31.74 M) | ||||
| Working Capital | 244.34 K | ||||
| Net Asset | 2.54 M |
About Avricore Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avricore Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avricore Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avricore Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avricore Stock Analysis
When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.